Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Premedication with intranasal dexmedetomidine in sedation of patients undergoing total knee arthroplasty (TKADEX)
2019-003795-39Phase 4Completed
- Sponsor
- Turku University Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in knee osteoarthritis (OA) (2 arms), sponsored by Turku University Hospital. Primary endpoint: Postoperative pain (visual analogue score). Started Dec 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2019-003795-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003795-39.